262 related articles for article (PubMed ID: 33252634)
1. Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
Kato Y; Oguchi Y; Omori T; Shintake H; Tomita R; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Machida T; Sekine H; Sekiryu T
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):39. PubMed ID: 33252634
[TBL] [Abstract][Full Text] [Related]
2. Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration.
Kato Y; Oguchi Y; Omori T; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Ishida Y; Machida T; Sekine H; Sekiryu T
Ophthalmol Sci; 2022 Jun; 2(2):100167. PubMed ID: 36249678
[TBL] [Abstract][Full Text] [Related]
3. Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
Hata M; Yamashiro K; Ooto S; Oishi A; Tamura H; Miyata M; Ueda-Arakawa N; Takahashi A; Tsujikawa A; Yoshimura N
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):292-298. PubMed ID: 28114590
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients.
Zhou H; Zhao X; Yuan M; Chen Y
BMC Ophthalmol; 2020 Jan; 20(1):15. PubMed ID: 31914968
[TBL] [Abstract][Full Text] [Related]
5. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
Sakurada Y; Nakamura Y; Yoneyama S; Mabuchi F; Gotoh T; Tateno Y; Sugiyama A; Kubota T; Iijima H
Ophthalmic Res; 2015; 53(1):2-7. PubMed ID: 25472810
[TBL] [Abstract][Full Text] [Related]
6. Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration.
Terao N; Koizumi H; Kojima K; Yamagishi T; Yamamoto Y; Yoshii K; Kitazawa K; Hiraga A; Toda M; Kinoshita S; Sotozono C; Hamuro J
Sci Rep; 2018 Jul; 8(1):10520. PubMed ID: 30002400
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy.
Yoon J; Yoon W; Na SK; Lee J; Kim CG; Kim JW; Cho HJ
Sci Rep; 2021 Jun; 11(1):12052. PubMed ID: 34103603
[TBL] [Abstract][Full Text] [Related]
8. Evidence for Activation of Lectin and Classical Pathway Complement Components in Aqueous Humor of Neovascular Age-Related Macular Degeneration.
Omori T; Oguchi Y; Machida T; Kato Y; Ishida Y; Ojima A; Itagaki K; Shintake H; Tomita R; Kasai A; Sugano Y; Ogasawara M; Sekine H; Sekiryu T
Ophthalmic Res; 2020; 63(3):252-258. PubMed ID: 31645047
[TBL] [Abstract][Full Text] [Related]
9. Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum-pathogenesis, imaging and available treatment options.
Sartini F; Figus M; Casini G; Nardi M; Posarelli C
Int Ophthalmol; 2020 Dec; 40(12):3577-3589. PubMed ID: 32729062
[TBL] [Abstract][Full Text] [Related]
10. Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease.
Tanaka K; Oguchi Y; Omori T; Ishida Y; Shintake H; Tomita R; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Machida T; Sekine H; Sekiryu T
Sci Rep; 2021 Apr; 11(1):8464. PubMed ID: 33875685
[TBL] [Abstract][Full Text] [Related]
11. Progression of Pachychoroid Neovasculopathy into Aneurysmal Type 1 Choroidal Neovascularization or Polypoidal Choroidal Vasculopathy.
Siedlecki J; Klaas JE; Keidel LF; Asani B; Luft N; Priglinger SG; Schworm B
Ophthalmol Retina; 2022 Sep; 6(9):807-813. PubMed ID: 35398547
[TBL] [Abstract][Full Text] [Related]
12. Highly Expressed Amyloid Beta-42 Of Aqueous Humor In Patients With Neovascular Macular Degeneration.
Zhu J; Su T; Wang M; Li M; Liu L; Wang F
Semin Ophthalmol; 2021 Feb; 36(1-2):9-13. PubMed ID: 33587673
[No Abstract] [Full Text] [Related]
13. Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy.
Yamashiro K; Yanagi Y; Koizumi H; Matsumoto H; Cheung CMG; Gomi F; Iida T; Tsujikawa A
J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956229
[TBL] [Abstract][Full Text] [Related]
14. Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration.
Kuranami A; Maruko R; Maruko I; Hasegawa T; Iida T
Sci Rep; 2023 May; 13(1):7379. PubMed ID: 37149627
[TBL] [Abstract][Full Text] [Related]
15. Intraocular and systemic inflammation-related cytokines during one year of ranibizumab treatment for neovascular age-related macular degeneration.
Fauser S; Viebahn U; Muether PS
Acta Ophthalmol; 2015 Dec; 93(8):734-8. PubMed ID: 26016605
[TBL] [Abstract][Full Text] [Related]
16. Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization.
Sun T; Wei Q; Gao P; Zhang Y; Peng Q
Drug Des Devel Ther; 2021; 15():2457-2467. PubMed ID: 34140764
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept.
Sato T; Enoki T; Karasawa Y; Someya H; Taguchi M; Harimoto K; Takayama K; Kanda T; Ito M; Takeuchi M
Front Immunol; 2021; 12():738521. PubMed ID: 34721402
[TBL] [Abstract][Full Text] [Related]
18. Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection.
Agawa T; Usui Y; Wakabayashi Y; Okunuki Y; Juan M; Umazume K; Kezuka T; Takeuchi M; Yamauchi Y; Goto H
Retina; 2014 Sep; 34(9):1811-8. PubMed ID: 24801651
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.
Matsumoto H; Hiroe T; Morimoto M; Mimura K; Ito A; Akiyama H
Jpn J Ophthalmol; 2018 Mar; 62(2):144-150. PubMed ID: 29411171
[TBL] [Abstract][Full Text] [Related]
20. Association of Upregulated Angiogenic Cytokines With Choroidal Abnormalities in Chronic Central Serous Chorioretinopathy.
Terao N; Koizumi H; Kojima K; Yamagishi T; Nagata K; Kitazawa K; Yamamoto Y; Yoshii K; Hiraga A; Toda M; Kinoshita S; Sotozono C; Hamuro J
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5924-5931. PubMed ID: 30551200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
